One of the most common concerns with extracorporeal therapies like EBOO (Extracorporeal Blood Oxygenation and Ozonation) is the potential for blood clotting. Since blood is removed, treated, and returned to the body in real time, precautions must be taken to prevent clot formation during the session.
Why Blood Clotting Is a Concern
When blood is exposed to tubing, filters, and oxygen outside the body, it can react by initiating a clotting response—a natural defense mechanism. Without proper safeguards, this could interfere with the treatment process or, in rare cases, pose a medical risk.
How EBOO Prevents Clots
Qualified clinics and trained practitioners follow strict safety protocols, including:
- Heparin administration: A low-dose anticoagulant (usually heparin) is given during treatment to prevent clotting inside the extracorporeal circuit.
- Sterile, medical-grade tubing and filters: These materials are designed to be biocompatible, reducing the risk of triggering coagulation.
- Continuous flow monitoring: The system is closely monitored to maintain optimal blood flow rates and ensure no stagnation occurs.
- Professional oversight: The procedure is typically managed by trained medical personnel who watch for any signs of clotting or adverse reactions in real time.
Who Should Be Cautious?
Patients with:
- A history of bleeding disorders
- Current anticoagulant therapy
- Severe thrombocytopenia (low platelet count)
… should undergo careful evaluation before proceeding with EBOO. In some cases, alternative detoxification therapies may be recommended.
